2007 Annual Shareholder Meeting: WACKER confirms positive Outlook for current Fiscal Year

- SUPERVISORY AND EXECUTIVE BOARDS’ PROPOSALS ADOPTED BY A LARGE
MAJORITY - 2006 DIVIDEND RAISED TO €2.00 PER SHARE, PLUS A SPECIAL
BONUS OF €0.50 - WACKER’S GROWTH CONTINUES IN Q1 2007 - FULL-YEAR
SALES INCREASE EXPECTED TO EXCEED 10 PERCENT, WITH A HIGHER EBITDA
MARGIN THAN LAST YEAR

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

companies

Munich (euro adhoc) - May 29, 2007 - Wacker Chemie AG confirmed its
positive 2007 sales and earnings forecast at the first Annual
Shareholder Meeting since its April 2006 IPO. Based on current
exchange rates, the MDAX-listed Group expects sales in 2007 to be
over 10 percent higher than last year. As for earnings, the EBITDA
margin is estimated to show further increase. After posting its best
results in over 90 years, the Munich-based chemical company is paying
out a total of EUR124.2 million (2006: EUR70.9m) to its shareholders.
This means each dividend-bearing share has earned EUR2, up from last
year´s EUR1.60. Additionally, the shareholders approved a one-time
special bonus of EUR0.50 per dividend-bearing share. They also
adopted the Supervisory and Executive Boards´ other proposals by
large majorities.

WACKER´s 2006 sales and earnings figures marked a new all time high.
Sales increased 21 percent to EUR3.34 billion (2005: EUR2.76bn), with
net profit more than doubling to EUR311.3 million (2005: EUR143.7m).

The Group´s growth continued seamlessly into the first quarter of
2007. Q1 sales rose to EUR943.7 million, 18 percent above the
EUR798.5 million posted in Q1 2006. First-quarter net profit soared
73 percent from EUR66.2 million to EUR114.5 million.

"Across the board, our figures clearly show we are on the right
track," said CEO Peter-Alexander Wacker in Munich today. "Each of our
key business sectors is making good progress. What´s more, business
is also profiting from renewable energy and other global trends, such
as energy-efficient construction and inroads made by electronics into
ever-more applications and walks of life. Consequently, I´m
optimistic that WACKER will continue benefiting from the economy´s
strength with above-average growth."

Resolutions and Voting Results At today´s Annual Shareholder Meeting,
43,354,345 voting shares were represented - 83.13 percent of all
eligible shares (number of shares outstanding: 49,677,983). The
voting results were as follows for agenda topics 2 through 7:

Topic 2: Resolution on the Appropriation of Net Retained Profit The
Executive and Supervisory Boards proposed net retained profit for
fiscal 2006, amounting to EUR763.6 million, to be appropriated as
follows: EUR124.2 million to be paid to shareholders, EUR315 million
to be kept as retained earnings and EUR324.4 million to be carried
forward to new account. The proposal was adopted. The result was: -
43,100,266 Yes votes (99.99 percent) - 876 No votes

Topic 3: Resolution on the Ratification of the Acts of the Executive
Board The Executive and Supervisory Boards´ proposal to ratify the
acts of the members of Wacker Chemie AG´s Executive Board during
fiscal 2006 was adopted. The result was: - 43,000,586 Yes votes
(99.99 percent) - 180 No votes

Topic 4: Resolution on the Ratification of the Acts of the
Supervisory Board The Executive and Supervisory Boards´ proposal to
ratify the acts of the members of Wacker Chemie AG´s Supervisory
Board during fiscal 2006 was adopted. The result was: - 43,024,023
Yes votes (99.99 percent) - 219 No votes

Topic 5: Resolution on the Appointment of Auditor The Supervisory
Board´s proposal to appoint KPMG as auditor for fiscal 2007 was
adopted. The result was: - 43,323,500 Yes votes (99.95 percent) -
20,681 No votes

Topic 6: Approval of the Profit-and-Loss Transfer Agreement between
Wacker Biotech GmbH and Wacker Chemie AG The Executive and
Supervisory Boards´ proposal to approve the profit-and-loss transfer
agreement between Wacker Biotech GmbH and Wacker Chemie AG was
adopted. The result was: - 43,084,297 Yes votes (99.99 percent) - 97
No votes

Topic 7: Authorization to Acquire Treasury Shares The Executive and
Supervisory Boards´ proposal to authorize the Executive Board to
acquire treasury shares representing up to 10 percent of the current
share capital was adopted. The result was: - 43,068,830 Yes votes
(99.94 percent) - 25,336 No votes

Information for editorial offices: All documents relating to the 2007
Annual Shareholding Meeting of Wacker Chemie AG can be downloaded
from WACKER´s website (www.wacker.com) under Investor Relations.

This press release contains forward-looking statements based on
assumptions and estimates of WACKER´s Executive Board. Although we
assume the expectations in these forward-looking statements are
realistic, we cannot guarantee they will prove to be correct. The
assumptions may harbor risks and uncertainties that may cause the
actual figures to differ considerably from the forward-looking
statements. Factors that may cause such discrepancies include, among
other things, changes in the economic and business environment,
variations in exchange and interest rates, the introduction of
competing products, lack of acceptance for new products or services,
and changes in corporate strategy. WACKER does not plan to update the
forward-looking statements, nor does it assume the obligation to do
so.

This press release contains statements about the resolutions of the
2007 Annual Shareholder Meeting. These statements serve the sole
purpose of providing an overview. They may not always correspond to
the exact wording and full extent of the resolutions adopted at the
Annual Shareholder Meeting.

end of announcement euro adhoc 29.05.2007 14:31:07
--------------------------------------------------------------------------------

ots Originaltext: Wacker Chemie AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:
Christof Bachmair
Media Relations & Information
Tel.: +49 (0)89 6279 1830
E-Mail: christof.bachmair@wacker.com

Branche: Chemicals
ISIN: DE000WCH8881
WKN: WCH888
Index: CDAX, Classic All Share, HDAX, MDAX, Midcap Market Index,
Prime All Share
Börsen: Frankfurter Wertpapierbörse / official dealing/prime standard